Annual Retained Earnings
-$967.62 M
-$328.07 M-51.30%
December 31, 2023
Summary
- As of February 12, 2025, RXRX annual retained earnings is -$967.62 million, with the most recent change of -$328.07 million (-51.30%) on December 31, 2023.
- During the last 3 years, RXRX annual retained earnings has fallen by -$754.02 million (-353.00%).
- RXRX annual retained earnings is now -664.34% below its all-time high of -$126.59 million, reached on December 31, 2019.
Performance
RXRX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.25 B
-$95.84 M-8.29%
September 30, 2024
Summary
- As of February 12, 2025, RXRX quarterly retained earnings is -$1.25 billion, with the most recent change of -$95.84 million (-8.29%) on September 30, 2024.
- Over the past year, RXRX quarterly retained earnings has dropped by -$193.38 million (-18.26%).
- RXRX quarterly retained earnings is now -486.32% below its all-time high of -$213.60 million, reached on December 1, 2020.
Performance
RXRX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RXRX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.3% | -18.3% |
| 3 y3 years | -353.0% | -95.8% |
| 5 y5 years | -664.3% | -95.8% |
RXRX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -141.9% | at low | -213.0% | at low |
| 5 y | 5-year | -664.3% | at low | -486.3% | at low |
| alltime | all time | -664.3% | at low | -486.3% | at low |
Recursion Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.25 B(+8.3%) |
| Jun 2024 | - | -$1.16 B(+9.2%) |
| Mar 2024 | - | -$1.06 B(+9.4%) |
| Dec 2023 | -$967.62 M(+51.3%) | -$967.62 M(+10.6%) |
| Sep 2023 | - | -$874.63 M(+11.9%) |
| Jun 2023 | - | -$781.61 M(+10.9%) |
| Mar 2023 | - | -$704.88 M(+10.2%) |
| Dec 2022 | -$639.56 M | -$639.56 M(+9.9%) |
| Sep 2022 | - | -$582.06 M(+11.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -$521.62 M(+14.4%) |
| Mar 2022 | - | -$456.06 M(+14.0%) |
| Dec 2021 | -$400.08 M(+87.3%) | -$400.08 M(+19.4%) |
| Sep 2021 | - | -$335.15 M(+16.5%) |
| Jun 2021 | - | -$287.72 M(+17.8%) |
| Mar 2021 | - | -$244.32 M(+14.4%) |
| Dec 2020 | -$213.60 M(+68.7%) | - |
| Dec 2020 | - | -$213.60 M |
| Dec 2019 | -$126.59 M | - |
FAQ
- What is Recursion Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual retained earnings year-on-year change?
- What is Recursion Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly retained earnings year-on-year change?
What is Recursion Pharmaceuticals annual retained earnings?
The current annual retained earnings of RXRX is -$967.62 M
What is the all time high annual retained earnings for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual retained earnings is -$126.59 M
What is Recursion Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, RXRX annual retained earnings has changed by -$328.07 M (-51.30%)
What is Recursion Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of RXRX is -$1.25 B
What is the all time high quarterly retained earnings for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly retained earnings is -$213.60 M
What is Recursion Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, RXRX quarterly retained earnings has changed by -$193.38 M (-18.26%)